Drug Development Strategy
End-to-end clinical R&D strategy from IND-enabling studies through NDA submission, with rigorous protocol design tailored to mechanism and indication.
Strategic Drug Development & Digital Health for CNS and Psychiatry
MindPath Pharma Consulting provides specialized guidance in clinical R&D strategy, digital therapeutics, and regulatory science — with deep expertise in addiction medicine and mental health.
What We Do
Core Capabilities
Addiction & Mental Health
Deep domain expertise in substance use disorders, depression, anxiety, and psychiatric indications — from target validation to pivotal trial design.
Digital Therapeutics
Strategic guidance for prescription digital therapeutics (PDTs) — regulatory pathway selection, clinical validation design, and market access planning.
Engagements
Three ways to work together
MindPath is a parallel advisory track alongside ongoing C-suite work. Engagements are accepted when capacity allows, and are screened for conflicts.
Focused review
Protocol, IND, or FDA briefing — a bounded deliverable for a critical decision point.
Fractional CMO / Head of R&D
Ongoing senior development leadership, calibrated to program stage and available capacity.
Investor or board diligence
Independent clinical and regulatory read of a CNS, psychiatry, or digital therapeutics asset.
Ready to Accelerate Your Program?
Whether you need a full strategic partner or targeted expertise for a critical decision point, MindPath delivers senior-level guidance calibrated to your program's stage and goals.
Get in Touch